- Home
- GRX vs DERM Comparison
GRX vs DERM Comparison
Compare GRX & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRX
- DERM
- Stock Information
- Founded
- GRX 2007
- DERM 2014
- Country
- GRX United States
- DERM United States
- Employees
- GRX N/A
- DERM N/A
- Industry
- GRX Finance/Investors Services
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- GRX Finance
- DERM Health Care
- Exchange
- GRX Nasdaq
- DERM Nasdaq
- Market Cap
- GRX 145.5M
- DERM 165.6M
- IPO Year
- GRX N/A
- DERM 2021
- Fundamental
- Price
- GRX $9.16
- DERM $7.27
- Analyst Decision
- GRX
- DERM Strong Buy
- Analyst Count
- GRX 0
- DERM 3
- Target Price
- GRX N/A
- DERM $12.67
- AVG Volume (30 Days)
- GRX 39.7K
- DERM 130.0K
- Earning Date
- GRX 01-01-0001
- DERM 11-11-2025
- Dividend Yield
- GRX 5.98%
- DERM N/A
- EPS Growth
- GRX N/A
- DERM N/A
- EPS
- GRX 0.26
- DERM N/A
- Revenue
- GRX N/A
- DERM $56,397,000.00
- Revenue This Year
- GRX N/A
- DERM $26.25
- Revenue Next Year
- GRX N/A
- DERM $52.96
- P/E Ratio
- GRX $38.50
- DERM N/A
- Revenue Growth
- GRX N/A
- DERM N/A
- 52 Week Low
- GRX $7.73
- DERM $3.54
- 52 Week High
- GRX $10.40
- DERM $8.90
- Technical
- Relative Strength Index (RSI)
- GRX 33.40
- DERM 51.37
- Support Level
- GRX $9.33
- DERM $7.00
- Resistance Level
- GRX $9.22
- DERM $7.12
- Average True Range (ATR)
- GRX 0.08
- DERM 0.27
- MACD
- GRX -0.04
- DERM 0.00
- Stochastic Oscillator
- GRX 2.27
- DERM 61.78
About GRX The Gabelli Healthcare & Wellness Trust of Beneficial Interest
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.